Diabetic dyslipidemia and the heart.
Vasudevan
Abu R
AR
Center for Cadiovascular Disease Prevention, Lipoprotein and Atherosclerosis Research Section, Baylor College of Medicine, Houston, TX 77030, USA.
Garber
Alan J
AJ
D017677:Age Distribution; D003324:Coronary Artery Disease / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology; D003925:Diabetic Angiopathies / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy; D018450:Disease Progression; D050171:Dyslipidemias / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology; D005260:Female; D006333:Heart Failure / Q000453:epidemiology / Q000517:prevention & control*; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D015994:Incidence; D008297:Male; D011379:Prognosis; D018570:Risk Assessment; D012720:Severity of Illness Index; D017678:Sex Distribution; D016019:Survival Analysis
D000960:Hypolipidemic Agents